☆ 4.7 Review

Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring

MOLECULAR CANCER (2022)

Related references

Note: Only part of the references are listed.
Article Ophthalmology

Metastatic Choroidal Melanoma Presenting as Neovascular Glaucoma

Gregory Fliney et al.

Summary: This case report highlights a rare presentation of uveal melanoma as neovascular glaucoma and emphasizes the importance of a complete ophthalmic evaluation in cases presenting with neovascular glaucoma to exclude the presence of a potentially life-threatening intraocular tumor.

CASE REPORTS IN OPHTHALMOLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Therapeutic advances of miRNAs: A preclinical and clinical update

Chiranjib Chakraborty et al.

Summary: This review discusses the current status of miRNAs as biopharmaceuticals, the clinical trials of miRNA therapeutics, and recent advancements in the absorption, distribution, metabolism, excretion, and delivery system of miRNAs.

JOURNAL OF ADVANCED RESEARCH (2021)

Add to Collection
Review Biochemistry & Molecular Biology

The Epigenetic landscape of Circulating tumour cells

Sai Shyam Vasantharajan et al.

Summary: Cancer metastasis is a major cause of high mortality rates, with CTCs potentially serving as minimally invasive biomarkers for early detection and therapeutic monitoring. However, research on CTCs is limited due to their low numbers and the lack of robust isolation methods. Molecular characterization of CTCs is needed to identify tumor-specific features for clinical implications.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents

Takshveer Singh et al.

Summary: Non-small cell lung cancer (NSCLC) is the most common and fatal type of primary lung malignancies, with poor outcomes despite advances in surgery, chemotherapy, and targeted therapies. Immunotherapy presents opportunities for potential improvements in NSCLC management, with various immunotherapeutics approved for clinical use. Ongoing studies are exploring novel targets, therapeutic vaccination, tumor genome modification, and improvements in drug delivery systems for future advancements in NSCLC treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Add to Collection
Article Oncology

NK cells-directed therapies target circulating tumor cells and metastasis

Hassan Dianat-Moghadam et al.

Summary: Metastasis is a major cause of cancer-related deaths, with CTCs playing a critical role in this process. Understanding the interaction between immune cells and CTCs, particularly the role of NK cells in recognizing and eliminating CTCs, may lead to new targeted immunotherapies for metastatic diseases.

CANCER LETTERS (2021)

Add to Collection
Article Oncology

Circulating microbiome DNA: An emerging paradigm for cancer liquid biopsy

Haiming Chen et al.

Summary: Dysbiosis of the human microbiome has been linked to various cancers, with differential microbiome composition potentially serving as novel biomarkers for cancer detection and immunotherapy success. Furthermore, circulating microbiome DNA alterations have shown promise as noninvasive biomarkers for cancer detection, with distinct bacterial DNA able to differentiate cancer patients from healthy individuals.

CANCER LETTERS (2021)

Add to Collection
Article Oncology

Bispecific antibody CD73xEpCAM selectively inhibits the adenosine-mediated immunosuppressive activity of carcinoma-derived extracellular vesicles

Emily M. Ploeg et al.

Summary: This study introduced a novel bispecific antibody CD73xEpCAM, which selectively inhibits CD73 exposed on tumor-derived EVs, reducing their immunosuppressive effects and offering a potential new approach for cancer immunotherapy.

CANCER LETTERS (2021)

Add to Collection
Article Oncology

Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer

Ryosuke Fujisawa et al.

Summary: Early changes in circulating tumor DNA (ctDNA) following the first cycle of chemotherapy accurately predict later treatment responses in esophageal squamous cell cancer (ESCC) patients. The study shows that the dynamics of ctDNA can better predict total volume reductions and overall survival rates in ESCC patients.

CARCINOGENESIS (2021)

Add to Collection
Article Oncology

Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway

Xiangdong Xu et al.

Summary: MiR-375 expression is downregulated in gliomas, and it suppresses glioma proliferation, migration, and invasion by inhibiting the CTGF-EGFR signaling pathway. MiR-375-containing exosomes were found in human blood samples from glioma patients, with levels correlating with disease progression. Exosomal miR-375 secretion impacts the activity of the CTGF-EGFR pathway, and once secreted, exosomal miR-375 is not taken back up by glioma cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection
Article Oncology

Identification of diverse tumor endothelial cell populations in malignant glioma

Jeff C. Carlson et al.

Summary: This study established molecular and morphological benchmarks for tumor associated vessels and tumor derived endothelial cells during glioblastoma progression. The research found progressive alteration of vessel function and morphogenesis over time, with TDECs identified as a rare subpopulation contributing to vessels within the tumor. Additionally, transcriptional profiling demonstrated molecular distinctiveness and extensive heterogeneity within both TAVs and TDECs, with these findings also present in human glioma.

NEURO-ONCOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells

Daolu Yang et al.

Summary: lncRNA linc00665 is significantly upregulated in NSCLC tissues, affecting drug sensitivity and tumor progression. The study demonstrates that linc00665 inhibits CDKN1C transcription by recruiting EZH2, thus influencing NSCLC cell proliferation and migration.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Article Medicine, Research & Experimental

Roles of circRNAs on tumor autophagy

Wenming Cui et al.

Summary: circRNAs are a type of stable noncoding RNA found mainly in the cytoplasm, playing important biological functions, especially in the process of autophagy. They can regulate gene expression, bind to RBPs, encode proteins, regulate alternative splicing, and play crucial roles in various diseases.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Article Medicine, Research & Experimental

Engineering highly efficient backsplicing and translation of synthetic circRNAs

Rita M. Meganck et al.

Summary: Research on circRNAs identified the importance of intron type and length, Alu repeats, IRES elements, and exon length in circRNA formation. Modulating these elements can enhance the design and expression of synthetic circRNAs.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Article Multidisciplinary Sciences

Lung cancer dynamics using fractional order impedance modeling on a mimicked lung tumor setup

Maria Ghita et al.

Summary: The study aims to investigate how the presence of tumorous tissue in the lung alters the parameters of proposed models; significant differences were found in the respiratory impedance model and nonlinearity index between mimicked healthy and tumor measurements.

JOURNAL OF ADVANCED RESEARCH (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

Xiaoqi Mao et al.

Summary: CAFs, as a crucial component of TME, play significant roles in promoting tumor growth, invasion, and metastasis. The interaction between CAFs and tumor cells, as well as immune cells in TIME, is critical for tumor progression.

MOLECULAR CANCER (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesicles

Yoshihiko Kakiuchi et al.

Summary: The study demonstrates that local treatment with OBP-301 has the potential to produce abscopal effects through tumor-derived EVs.

MOLECULAR THERAPY (2021)

Add to Collection
Editorial Material Multidisciplinary Sciences

A deep dive into local mRNA translation in neurons

Mauricio M. Oliveira et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection
Editorial Material Cell Biology

Making more exosomes

Kim Baumann

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution

Lei Zhao et al.

Summary: In this study, an efficient workflow LCM-mu WGBS was introduced to profile the DNA methylome of circulating tumor cells from lung cancer patients. A unique DNA methylation signature of CTCs distinct from primary lung cancer tissues was identified, with promoter hypermethylation of epithelial genes as a hallmark of stable epithelial-mesenchymal transition. Furthermore, CTCs may exhibit a stemness-related feature during dissemination and metastasis, providing potential noninvasive CTC DNA methylation biomarkers for clinical diagnosis.

ONCOGENE (2021)

Add to Collection
Article Oncology

Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

Alireza Labani-Motlagh et al.

Summary: The study demonstrates that exosomes released by tumor cells infected with armed oncolytic viruses may contribute to activating the immune system, supporting systemic immunity. These exosomes can locally activate immune responses at the tumor site and interact with immune cells such as dendritic cells (DCs).

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Multidisciplinary Sciences

Separation of ctDNA by superparamagnetic bead particles in microfluidic platform for early cancer detection

Samla Gauri Balakrishnan et al.

Summary: This study aims to simulate the extraction and separation of ctDNA from the blood plasma of cancer patients for early and effective cancer detection. The results showed efficient separation of ctDNA for early cancer management, with a high sensitivity and specificity in tracing ctDNA using a microfluidics platform and SPM bead particles.

JOURNAL OF ADVANCED RESEARCH (2021)

Add to Collection
Article Biology

Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer

Marinus Huber et al.

Summary: Recent omics analyses of human biofluids have led to the development of a high-throughput onco-IR-phenotyping method for breast, bladder, prostate, and lung cancer diagnosis. The FTIR spectroscopy showed promising results in detecting cancer with binary classification performance ranging from 0.78-0.89 (AUC). This study provides a cost-effective, complementary analytical tool for disease recognition.

ELIFE (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease

Olivia M. de Goede et al.

Summary: This study systematically characterized 14,100 lncRNA genes across 49 tissues for 101 complex genetic traits using GTEx project data, identifying 1,432 lncRNA gene-trait associations, 800 of which were not explained by neighboring protein-coding genes. The findings revealed associations between lncRNA and various diseases and traits.

CELL (2021)

Add to Collection
Review Medicine, Research & Experimental

Emerging roles of circRNAs in the pathological process of myocardial infarction

Zeng-Jin Wen et al.

Summary: Myocardial infarction (MI) is one of the leading causes of morbidity and mortality worldwide, requiring further investigation of novel biomarkers and molecular therapeutic targets.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Review Oncology

Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer

Michael Burke et al.

Summary: Immune-related adverse events from immunotherapy in NSCLC present challenges in diagnosis and management, requiring interdisciplinary efforts. Future directions may involve identifying potential biomarkers for better recognition of toxicities.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Article Pharmacology & Pharmacy

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

Simon Heeke et al.

Summary: The study assessed a fully automated cartridge-based qPCR test for automatic detection of EGFR mutations from plasma in NSCLC patients. While promising in accuracy, protocol adjustments are needed to reduce the high test failure rate.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Review Oncology

Progress and application of circulating tumor cells in non-small cell lung cancer

Huizhu Qian et al.

Summary: Liquid biopsy, focusing on circulating tumor cells (CTCs), shows promise in aiding the diagnosis, prognostic assessment, and therapy of NSCLC. Traditional biopsy methods have limitations in reflecting the true condition of tumors, while liquid biopsy provides additional information for clinicians and offers a new approach for the treatment of lung cancer patients.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Oncology

A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation

Pratik S. Bhojnagarwala et al.

Summary: Neoantigens are tumor-specific antigens resulting from somatic mutations, ideal targets for cancer immunotherapy with minimal risk for on-target toxicities. Targeting multiple neoantigens helps better control tumors, and multi-epitope antigens can induce long-term immunity.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Multidisciplinary Sciences

RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy

Shu-Hui Wu et al.

Summary: The study demonstrates that Dox-gluRDVs exhibit superior anticancer activity compared to free Dox by efficiently delivering the majority of their conjugated Dox into lysosomes, resulting in mitochondrial ROS overproduction and activation of apoptotic signaling for enhanced anticancer activity.

JOURNAL OF ADVANCED RESEARCH (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Somatic Copy-Number Alterations in Plasma Circulating Tumor DNA from Advanced EGFR-Mutated Lung Adenocarcinoma Patients

Anna Buder et al.

Summary: The presence of resistance-related gene SCNAs in plasma before the initiation of osimertinib therapy is associated with lower response rate and shorter progression-free and overall survival.

BIOMOLECULES (2021)

Add to Collection
Article Oncology

True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature

Chiara Nicolazzo et al.

Summary: The lack of targeted treatments in RAS mutant colorectal cancers leads to poorer prognosis compared to RAS wild-type disease. Liquid biopsy studies have shown that RAS mutant clones may disappear in plasma during clonal evolution, potentially enabling new possibilities for EGFR blockade. However, the detection of RAS mutations in plasma may be hindered by the low levels of circulating ctDNA, necessitating a more precise selection of true RAS mutation converters. In this study, evaluating RAS mutational status at the time of disease progression in initially RAS-mutant patients revealed a 37.5% incidence of true RAS converters, with a trend towards improved PFS in patients receiving anti-EGFR treatment as second or subsequent lines.

CANCER LETTERS (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms

Chunyang Jiang et al.

Summary: Exosomes play a crucial role in the communication between tumor cells and their microenvironment, especially in the development of lung cancer metastasis. Studies have shown that tumor-derived exosomes promote lung cancer via processes such as inducing epithelial-mesenchymal transition. Understanding these mechanisms provides researchers with new ideas to explore clinical applications for the diagnosis and treatment of lung cancer metastasis.

MOLECULAR CANCER (2021)

Add to Collection
Article Oncology

Role of aneuploid circulating tumor cells and CD31(+) circulating tumor endothelial cells in predicting and monitoring anti-angiogenic therapy efficacy in advanced NSCLC

Tongmei Zhang et al.

Summary: Longitudinal monitoring and early detection of treatment resistance in cancer patients undergoing anti-angiogenic therapy is challenging. This study found that baseline Vim(+) CTECs and post-therapeutic EpCAM(+) CTCs and CTECs can serve as predictive biomarkers for monitoring response to anti-angiogenesis combination regimens in NSCLC patients.

MOLECULAR ONCOLOGY (2021)

Add to Collection
Article Multidisciplinary Sciences

Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells

Vincenza Cifarelli et al.

Summary: Genetic variants in CD36 impact lymphatic lipid transport, while deficiency of CD36 in lymphatic endothelial cells leads to risks associated with metabolic syndrome and diabetes. The loss of CD36 in mice causes lymph leakage, visceral adiposity and glucose intolerance, increasing the risk of type 2 diabetes (T2D).

NATURE COMMUNICATIONS (2021)

Add to Collection
Article Oncology

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis

Hao-Hua Zhu et al.

Summary: The study aimed to define the clinical significance of circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer (SCLC) patients. CTC-WBC clusters at baseline and after two-cycle chemotherapy, as well as the total CTC counts at the completion of chemotherapy, are strong predictors for the prognostic survival of SCLC patients receiving first-line treatment. Detection of CTC clusters and CTECs also showed prognostic values in SCLC patients.

THORACIC CANCER (2021)

Add to Collection
Article Pharmacology & Pharmacy

The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study

Zhong-Bin Li et al.

Summary: The study developed a novel algorithm, LAC, to improve the diagnosis accuracy of significant fibrosis in patients with chronic drug-induced liver injury. LAC showed a high AUROC value in the training cohort, indicating its potential to assess high-risk disease progression and establish optimal treatment strategies.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Article Pharmacology & Pharmacy

A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility

Jianping Wu et al.

Summary: Vimentin-binding compound R491 induces intracellular vacuolization in cancer cells and significantly reduces exosome release. Cells with lower vimentin levels have fewer exosomes, while R491 can decrease cancer cell migration and invasion in vitro and reduce exosome levels in mice. These findings suggest potential applications for inhibiting cancer invasive growth by targeting vimentin.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Article Pharmacology & Pharmacy

Exosome-Derived ADAM17 Promotes Liver Metastasis in Colorectal Cancer

Jinbing Sun et al.

Summary: Exosomes derived from cancer cells, particularly those containing elevated levels of ADAM17, play a role in promoting the migratory ability of colorectal cancer cells by cleaving E-cadherin junctions. This finding suggests that exosomal ADAM17 may serve as a blood-based biomarker for colorectal cancer metastasis.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection
Article Medicine, Research & Experimental

The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer

Dmitry Morozov et al.

Summary: Aptamers, short DNA or RNA molecules, bind to target molecules with specificity, with affinity depending on their tertiary structure and charge distribution. Optimizing length and structure is crucial for improving aptamer specificity and affinity. LC-18t, a truncated version of aptamer LC-18, showed stronger binding to cancerous cells in lung tumor tissues and shared the binding site with the original aptamer.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Review Medicine, Research & Experimental

Diverse RNAs in adipose-derived extracellular vesicles and their therapeutic potential

Pengyu Hong et al.

Summary: EVs play a crucial role as mediators in regulating intercellular communication and accelerating interorgan crosstalk by carrying various RNAs as bioactive cargoes. These RNAs are key players in processes such as cell differentiation, metabolic homeostasis, immune signal transduction, and cancer, and are also recognized as potential disease biomarkers and therapeutic nanodrugs.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Add to Collection
Review Oncology

Systematic review of the immunological landscape of Wilms tumors

Francesca Palmisani et al.

Summary: Immunotherapy results in childhood solid cancers, except for neuroblastoma, have been disappointing due to insufficient knowledge of tumor immunology. Wilms tumor patients have high cure rates but also face high toxicity, and treatment-resistant entities still pose challenges. Successful immunotherapy could offer a novel and potentially less-toxic treatment option for Wilms tumors.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Oncology

Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling

Aibin Liu et al.

Summary: ZIC2 was found to be upregulated in NSCLC tissues and high expression of ZIC2 correlated with worse overall and progression-free survival in NSCLC patients. Silencing ZIC2 inhibited tumorigenesis and reduced anoikis resistance in NSCLC cells. Further investigation revealed that silencing ZIC2 transcriptionally inhibited Src expression and inactivated steroid receptor coactivator/focal adhesion kinase signaling, thereby attenuating anoikis resistance in NSCLC cells.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Oncology

Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma

John D. Christie et al.

Summary: The engineered oncolytic myxoma virus expressing human tumor necrosis factor showed promising results in reducing tumor burden and increasing survival time in lung metastatic osteosarcoma. Additionally, it potentially synergized with established immune checkpoint inhibitors, highlighting its potential as a new strategy against lung metastatic cancers.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Add to Collection
Article Immunology

TRAP1 Shows Clinical Significance in the Early Diagnosis of Small Cell Lung Cancer

Xiaohang Li et al.

Summary: The study revealed that TRAP1 is lowly expressed in SCLC and negatively correlated with the disease occurrence, while MSA and Mad2 are highly expressed in SCLC. Combined analysis of TRAP1, MAD2 and MSA can improve the sensitivity and specificity for SCLC diagnosis.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Add to Collection
Article Immunology

Comparison of Radiation Pneumonitis in Lung Cancer Patients Treated with HT versus IMRT and Circulating Lymphocyte Subsets as Predicting Risk Factors

Xin Zhang et al.

Summary: The study compared symptomatic radiation pneumonitis (RP) in lung cancer patients treated with helical tomotherapy (HT) versus intensity-modulated radiotherapy (IMRT). IMRT was associated with lower lung V10 and less grade 5 RP than HT for stage III-IV lung cancer. Higher CD8(+) T cell count after radiotherapy was associated with an increased risk of RP, suggesting that HT may better preserve total T cell and CD4(+) T cell than IMRT.

JOURNAL OF INFLAMMATION RESEARCH (2021)

Add to Collection
Article Oncology

Comprehensive Genomic Profiling of Circulating Cell-Free DNA Distinguishes Focal MET Amplification from Aneuploidy in Diverse Advanced Cancers

Yuichi Kumaki et al.

Summary: This study describes a method to distinguish focal and non-focal MET amplification in advanced cancer patients using comprehensive genomic profiling of cfDNA. Focal MET amplification accounted for around 30% of all MET amplification, found in 3.7% of patients with diverse cancers and associated with a higher plasma copy number. Further clinical studies are needed to evaluate the clinical utility of targeted therapies for tumors with focal MET amplification detected by NGS of cfDNA.

CURRENT ONCOLOGY (2021)

Add to Collection
Article Biochemistry & Molecular Biology

Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial

Tao Jiang et al.

Summary: This study investigated the efficacy and predictive biomarkers of toripalimab plus chemotherapy in EGFR-mutant advanced NSCLC patients as second-line treatment. The combination therapy showed promising anti-tumor activity with acceptable safety profiles, and DSPP mutation might serve as a potential biomarker for this combination. Further phase-III trials are ongoing to compare toripalimab versus placebo in this setting.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection
Article Oncology

Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection

Dingtao Hu et al.

Summary: Using multiple online databases, we found that the mRNA expressions of H19 and MALAT1 in tissues were related to the occurrence of GC, and such expressions were associated with immune cell infiltration of GC and negatively correlated with DNA methylation levels of H19 and MALAT1. Statistically significant hypermethylation of H19 and MALAT1 promoters in GC patients was observed, and meaningful sensitivity and specificity of MALAT1 and H19 methylation in discriminating GC and HCs were found in both female and male groups, suggesting their potential as non-invasive biomarkers for GC diagnosis.

CANCER CONTROL (2021)

Add to Collection
Article Medicine, Research & Experimental

Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy

Jianbing Du et al.

Summary: This study successfully designed an exosome-based platform to deliver ferroptosis inducer and photosensitizer into liver cancer cells, inducing cell death significantly while minimizing toxicity to the liver and kidney.

THERANOSTICS (2021)

Add to Collection
Article Medicine, Research & Experimental

Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer

Qing Han et al.

Summary: SIRT6 expression is positively correlated with prostate cancer progression, and its loss significantly suppresses proliferation and metastasis of prostate cancer cells. Delivery of siRNA through engineered exosomes can effectively inhibit SIRT6 and consequently inhibit tumor growth and metastasis.

THERANOSTICS (2021)

Add to Collection
Article Medicine, Research & Experimental

Cellular senescence in hepatocellular carcinoma induced by a long non-coding RNA-encoded peptide PINT87aa by blocking FOXM1-mediated PHB2

Xiaohong Xiang et al.

Summary: This study identified PINT87aa as a novel biomarker and key regulator of cellular senescence in HCC, highlighting its potential as a therapeutic target for HCC.

THERANOSTICS (2021)

Add to Collection
Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Circulating tumour DNA: A new biomarker to monitor resistance in NSCLC patients treated with EGFR-TKIs

Zhenli Diao et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Add to Collection
Article Medicine, Research & Experimental

Targeting Circulating SINEs and LINEs with DNase I Provides Metastases Inhibition in Experimental Tumor Models

Ludmila A. Alekseeva et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Add to Collection
Article Multidisciplinary Sciences

Integrating genomic features for non-invasive early lung cancer detection

Jacob J. Chabon et al.

NATURE (2020)

Add to Collection
Article Oncology

Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system

Emilie Le Rhun et al.

CANCER LETTERS (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino et al.

CELL (2020)

Add to Collection
Article Oncology

Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer

Yuanyuan Lei et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2020)

Add to Collection
Article Multidisciplinary Sciences

Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis

Brisa Palikuqi et al.

NATURE (2020)

Add to Collection
Article Cell Biology

Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1

Hongbo Wu et al.

CELL DEATH & DISEASE (2020)

Add to Collection
Article Oncology

Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells

Jia-Bao Yan et al.

MOLECULAR THERAPY-ONCOLYTICS (2020)

Add to Collection
Review Oncology

The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis

Cecilia Pop-Bica et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection
Review Oncology

Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers

Le Zhang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection
Article Medicine, Research & Experimental

A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC

Minji Lim et al.

THERANOSTICS (2020)

Add to Collection
Article Multidisciplinary Sciences

Neutrophils escort circulating tumour cells to enable cell cycle progression

Barbara Maria Szczerba et al.

NATURE (2019)

Add to Collection
Article Biochemical Research Methods

RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA

Myron G. Best et al.

NATURE PROTOCOLS (2019)

Add to Collection
Article Medicine, General & Internal

Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness

Qianjun Zhou et al.

EBIOMEDICINE (2019)

Add to Collection
Article Multidisciplinary Sciences

Genome-wide cell-free DNA fragmentation in patients with cancer

Stephen Cristiano et al.

NATURE (2019)

Add to Collection
Article Medicine, Research & Experimental

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

Marianna Alunni-Fabbroni et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Add to Collection
Article Medicine, Research & Experimental

SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response

Yan Zong et al.

THERANOSTICS (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq

Shan Xing et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Add to Collection
Review Oncology

Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring

Myron G. Best et al.

CANCER RESEARCH (2018)

Add to Collection
Article Multidisciplinary Sciences

Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice

M. Brown et al.

SCIENCE (2018)

Add to Collection
Article Oncology

A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer

Dong Hang et al.

CANCER MEDICINE (2018)

Add to Collection
Article Nanoscience & Nanotechnology

Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner

Xiaobing Qin et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)

Add to Collection
Article Multidisciplinary Sciences

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Christopher Abbosh et al.

NATURE (2017)

Add to Collection
Article Oncology

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing

Xiance Jin et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection
Article Oncology

microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer

Riccardo Cazzoli et al.

JOURNAL OF THORACIC ONCOLOGY (2013)

Add to Collection
Article Multidisciplinary Sciences

A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells

Kim J. Png et al.

NATURE (2012)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.